Richard M. Rieder files SEC Form 4 disclosures for BlackRock Capital Allocation Trust. They have made 77 open-market trades across 4 companies since 2017, most recently 2026-07-13.
CIK 0001436848
63 open-market purchases totalling $23.6M since 2017, against 14 sales. Across 60 scored buys the stock is up 0.2% at ninety days, and 4.2 points behind the S&P over the same stretch.
60 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BCAT | 272,353 | $3.5M |
| ECAT | 141,464 | $1.9M |
| BGIO | 317,199 | $834K |
| MSO | 30,000 | — |
| PrivateUnlisted | 45,817 | — |
| Total | $6.3M |
Shares reported on the most recent Form 4, priced at the 2026-07-15 close. 2 holdings could not be priced and are excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 58% | 60% | 47% |
| Avg Move | +0.5% | +1.2% | +0.2% |
| Alpha | -0.8% | -1.6% | -4.2% |
| Scored | 60 | 60 | 60 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCAT | SELL | 2026-07-13 | 2026-07-15 | $15.96 | $570K | -1.6% | +1.5% | -12.6% |
| ECAT | BUY | 2026-07-13 | 2026-07-15 | $15.86 | $567K | -3.1% | -0.8% | -10.3% |
| ECAT | BUY | 2024-01-05 | 2024-01-09 | $16.20 | $113K | -0.3% | +2.7% | +3.6% |
| ECAT | SELL | 2023-11-08 | 2023-11-13 | $14.94 | $299K | +2.0% | +6.5% | +12.7% |
| BCAT | SELL | 2023-07-05 | 2023-07-07 | $15.36 | $585K | -0.2% | +1.0% | -7.5% |
| ECAT | BUY | 2022-12-28 | 2022-12-30 | $13.40 | $199K | +6.9% | +8.1% | +12.2% |
| BCAT | BUY | 2022-12-28 | 2022-12-30 | $13.76 | $200K | +5.9% | +6.3% | +6.8% |
| ECAT | BUY | 2021-11-30 | 2021-12-02 | $18.60 | $74K | -0.9% | +1.3% | -13.5% |
| ECAT | BUY | 2021-11-29 | 2021-12-01 | $18.98 | $228K | +1.1% | +0.6% | -13.7% |
| ECAT | BUY | 2021-11-26 | 2021-12-01 | $19.05 | $36K | +1.1% | +0.6% | -13.7% |
| ECAT | BUY | 2021-11-23 | 2021-11-26 | $19.41 | $1.0M | +0.4% | -2.6% | -15.9% |
| BCAT | BUY | 2021-10-18 | 2021-10-20 | $19.49 | $292K | +3.4% | +0.5% | -4.8% |
| BCAT | BUY | 2021-09-27 | 2021-09-29 | $19.95 | $496K | -2.1% | +0.1% | -6.2% |
| ECAT | BUY | 2021-09-27 | 2021-11-26 | $20.00 | $1.1M | +0.4% | -2.6% | -15.9% |
| BCAT | BUY | 2021-09-24 | 2021-09-28 | $20.12 | $994K | -0.1% | -0.6% | -4.8% |
| BCAT | BUY | 2021-05-25 | 2021-05-27 | $20.47 | $396K | +2.7% | +1.3% | +2.9% |
| BCAT | BUY | 2021-03-23 | 2021-03-25 | $19.99 | $200K | +4.8% | +6.8% | +5.1% |
| BCAT | BUY | 2021-03-22 | 2021-03-24 | $20.00 | $136K | +3.2% | +8.0% | +5.9% |
| BCAT | BUY | 2021-03-18 | 2021-03-22 | $20.34 | $16K | +1.7% | +6.5% | +6.0% |
| BCAT | BUY | 2021-03-16 | 2021-03-18 | $20.95 | $679K | -0.0% | +7.4% | +6.1% |
| BCAT | BUY | 2021-03-12 | 2021-03-17 | $21.05 | $250K | +0.7% | +8.0% | +8.6% |
| BCAT | BUY | 2021-03-10 | 2021-03-12 | $21.20 | $186K | -5.8% | +0.2% | +3.4% |
| BCAT | BUY | 2021-01-06 | 2021-01-07 | $21.70 | $174K | -4.4% | +2.6% | -6.7% |
| BCAT | BUY | 2020-12-08 | 2020-12-10 | $22.28 | $810K | +3.5% | -3.7% | -6.2% |
| BCAT | BUY | 2020-11-10 | 2020-11-12 | $20.60 | $165K | +1.2% | +9.5% | +15.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.